ALKERMES | Fortjeneste Per Aksje

Fiscal Kalender Faktiske Snittforvetning Forrige Dato
FY2024Q1 Mar/2024 0.60 0.01 May/01 2024
FY2023Q4 Dec/2023 0.22 0.45 0.14 Feb/15 2024
FY2023Q3 Sep/2023 0.64 0.42 0.02 Oct/25 2023
FY2023Q2 Jun/2023 0.55 0.63 0.06 Jul/26 2023
FY2023Q1 Mar/2023 0.01 -0.01 0.12 Apr/26 2023
FY2022Q4 Dec/2022 0.14 0.05 0.23 Feb/16 2023
FY2022Q3 Sep/2022 0.02 0.06 0.14 Nov/02 2022
FY2022Q2 Jun/2022 0.06 0.03 0.3 Jul/27 2022
FY2022Q1 Mar/2022 0.12 0.01 0.11 Apr/27 2022
FY2021Q4 Dec/2021 0.23 0.08 0.1 Feb/16 2022
FY2021Q3 Sep/2021 0.14 0.09 0.26 Oct/27 2021
FY2021Q2 Jun/2021 0.3 0.15 0.06 Jul/28 2021

Eps Endring Dato
AbbVie USD 2.79 0.16 2023-12
Acadia Pharmaceuticals USD 0.28 0.68 2023-12
ALKERMES USD 0.22 0.42 2023-12
Amgen USD 4.71 0.25 2023-12
Biogen USD 3.67 0.37 2024-03
BioMarin Pharmaceutical USD 0.18 0.03 2023-12
Bristol-Myers Squibb USD 1.7 0.3 2023-12
Eli Lilly USD 2.49 2.39 2023-12
Gilead Sciences USD 1.72 0.57 2023-12
Intra Cellular Therapies USD -0.3 0.05 2023-12
Ionis Pharmaceuticals USD -0.06 0.97 2023-12
J&J USD 2.71 0.42 2024-03
Malin Corporation -0.06 0.1 2023-12
Merck USD 0.03 2.1 2023-12
Neurocrine Biosciences USD 1.44 0.62 2023-12
Otsuka Holdings JPY -73.89 182.82 2023-12
Pfizer USD 0.1 0.27 2023-12
Regeneron Pharmaceuticals USD 11.86 0.27 2023-12
Vertex Pharmaceuticals USD 4.2 0.12 2023-12



ALKERMES Fortjeneste Per Aksje - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.